[1] ETHUN C G,BILEN M A,JANI A B,et al.Frailty and cancer:implications for oncology surgery,medical oncology,and radiation oncology[J]. CA Cancer J Clin,2017,67(5):362-377.
[2] SCHRANK Z,CHHABRA G,LIN L,et al.Current molecular-targeted therapies in NSCLC and their mechanism of resistance[J]. Cancers (Basel),2018,10(7):224.
[3] PANG X,CUI C,WAN S,et al.Bioapplications of cell-sELEX-generated aptamers in cancer diagnostics,therapeutics,theranostics and biomarker discovery:a comprehensive review[J]. Cancers (Basel),2018,10(2):47.
[4] LIEDTKE W,CHOE Y,MARTÍ-RENOM M A,et al.Vanilloid receptor-related osmotically activated channel (VR-OAC),a candidate vertebrate osmoreceptor[J]. Cell,2000,103(3):525-535.
[5] STROTMANN R,HARTENECK C,NUNNENMACHER K,et al.OTRPC4,a nonselective cation channel that confers sensitivity to extracellular osmolarity[J]. Nat Cell Biol,2000,2(10):695-702.
[6] WHITE J P,CIBELLI M,URBAN L,et al.TRPV4:molecular conductor of a diverse orchestra[J]. Physiol Rev,2016,96(3):911-973.
[7] WATANABE H,VRIENS J,JANSSENS A,et al.Modulation of TRPV4 gating by intra-and extracellular Ca2+[J]. Cell Calcium,2003,33(5-6):489-495.
[8] VINCENT F,DUNCTON M A.TRPV4 agonists and antagonists[J]. Curr Top Med Chem,2011,11(17):2216-2226.
[9] JIE P,TIAN Y,HONG Z,et al.Blockage of transient receptor potential vanilloid 4 inhibits brain edema in middle cerebral artery occlusion mice[J]. Front Cell Neurosci,2015,9:141.
[10] BALAKRISHNA S,SONG W,ACHANTA S,et al.TRPV4 inhibition counteracts edema and inflammation and improves pulmonary function and oxygen saturation in chemically induced acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol,2014,307(2):L158-L172.
[11] RANDHAWA P K,JAGGI A S.TRPV4 channels:physiological and pathological role in cardiovascular system[J]. Basic Res Cardiol,2015,110(6):54.
[12] GOLDENBERG N M,RAVINDRAN K,KUEBLER W M.TRPV4:physiological role and therapeutic potential in respiratory diseases[J]. Naunyn Schmiedebergs Arch Pharmacol,2015,388(4):421-436.
[13] THORNELOE K S,SULPIZIO A C,LIN Z,et al.N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A),a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity:Part Ⅰ[J]. J Pharmacol Exp Ther,2008,326(2):432-442.
[14] HOLZER P.Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system[J]. Pharmacol Ther,2011,131(1):142-170.
[15] MCNULTY A L,LEDDY H A,LIEDTKE W,et al.TRPV4 as a therapeutic target for joint diseases[J]. Naunyn Schmiedebergs Arch Pharmacol,2015,388(4):437-450.
[16] LIEDTKE W,FRIEDMAN J M.Abnormal osmotic regulation in trpv4-/-mice[J]. Proc Natl Acad Sci U S A,2003,100(23):13698-13703.
[17] MOORE C,GUPTA R,JORDT S E,et al.Regulation of pain and itch by TRP channels[J]. Neurosci Bull,2018,34(1):120-142.
[18] MA X,QIU S,LUO J,et al.Functional role of vanilloid transient receptor potential 4-canonical transient receptor potential 1 complex in flow-induced Ca2+ influx[J]. Arterioscler Thromb Vasc Biol,30(4):851-858
[19] 李龙均,付明刚.乳腺浸润性导管癌中PDGF-BB表达与预后的关系[J]. 现代医学,2020,48(9):1101-1106.
[20] LEE W H,CHOONG L Y,MON N N,et al.TRPV4 regulates breast cancer cell extravasation,stiffness and actin cortex[J]. Sci Rep,2016,6:27903.
[21] LEE W H,CHOONG L Y,JIN T H,et al.TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein[J]. Oncogenesis,2017,6(5):e338.
[22] PETERS A A,JAMALUDIN S Y N,YAPA K,et al.Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells[J]. Oncogene,2017,36(46):6490-6500.
[23] FIORIO PLA A,ONG H L,CHENG K T,et al.TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling[J]. Oncogene,2012,31(2):200-212.
[24] 李孝琼,陈莉,王昌梅.TRPV4对HeLa细胞增殖的作用[J]. 中华临床医师杂志(电子版),2013,7(7):2954-2956.
[25] LI X,CHENG Y,WANG Z,et al.Calcium and TRPV4 promote metastasis by regulating cytoskeleton through the RhoA/ROCK1 pathway in endometrial cancer[J]. Cell Death Dis,2020,11(11):1009.
[26] LIU X,ZHANG P,XIE C,et al.Activation of PTEN by inhibition of TRPV4 suppresses colon cancer development[J]. Cell Death Dis,2019,10(6):460.
[27] ARBABIAN A,IFTINCA M,ALTIER C,et al.Mutations in calmodulin-binding domains of TRPV4/6 channels confer invasive properties to colon adenocarcinoma cells[J]. Channels (Austin),2020,14(1):101-109.
[28] WANG H,ZHANG B,WANG X,et al.TRPV4 ovrexpression promotes metastasis through epithelial-mesenchymal transition in gastric cancer and correlates with poor prognosis[J]. Onco Targets Ther,2020,13:8383-8394.
[29] XIE R,XU J,XIAO Y,et al.Calcium promotes human gastric cancer via a novel coupling of calcium-sensing receptor and TRPV4 channel[J]. Cancer Res,2017,77(23):6499-6512.
[30] TANG B,WU J,ZHU M X,et al.VPAC1 couples with TRPV4 channel to promote calcium-dependent gastric cancer progression via a novel autocrine mechanism[J]. Oncogene,2019,38(20):3946-3961.
[31] IKAI I,ITAI Y,OKITA K,et al.Report of the 15th follow-up survey of primary liver cancer[J]. Hepatol Res,2004,28(1):21-29.
[32] 何瑾瑜,杨跃青.miR-210-3p通过下调USP10促进肝癌细胞的迁移和侵袭[J]. 现代医学,2020,48(9):1190-1196.
[33] VRIENS J,JANSSENS A,PRENEN J,et al.TRPV channels and modulation by hepatocyte growth factor/scatter factor in human hepatoblastoma(HepG2)cells[J]. Cell Calcium,2004,36(1):19-28.
[34] FANG Y,LIU G,XIE C,et al.Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of hepatocellular carcinoma via modulation of ERK signaling pathway[J]. Biomed Pharmacother,2018,101:910-919.
[35] 吕青,张恋茹,季留连,等.74例皮肤黑色素瘤的预后及影响因素分析[J]. 临床肿瘤学杂志,2017,22(3):249-254.
[36] WEINSTOCK M A.Epidemiologic investigation of nonmelanoma skin cancer mortality:the rhode island follow-back study[J]. J Invest Dermatol,1994,102(6):6s-9s.
[37] FUSI C,MATERAZZI S,MINOCCI D,et al.Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer[J]. J Invest Dermatol,2014,134(9):2408-2417.
[38] OLIVAN-VIGUERA A,GARCIA-OTIN A L,LOZANO-GERONA J,et al.Pharmacological activation of TRPV4 produces immediate cell damage and induction of apoptosis in human melanoma cells and HaCaT keratinocytes[J]. PLoS One,2018,13(1):e0190307.
[39] KONG X,WANG Y,LIU S,et al.Brain stem and entire spinal leptomeningeal dissemination of supratentorial glioblastoma multiforme in a patient during postoperative radiochemotherapy:case report and review of the literatures[J]. Medicine (Baltimore),2015,94(24):e962.
[40] MADANY M,THOMAS T M,EDWARDS L,et al.Immunobiology and immunotherapeutic targeting of glioma stem cells[J]. Adv Exp Med Biol,2015,853:139-166.
[41] 中国脑胶质瘤基因组图谱计划.中国脑胶质瘤分子诊疗指南[J]. 中华神经外科杂志,2014,30(5):435-444,523-527.
[42] OU-YANG Q,LI B,XU M,et al.TRPV4 promotes the migration and invasion of glioma cells via AKT/Rac1 signaling[J]. Biochem Biophys Res Commun,2018,503(2):876-881.
[43] YANG W,WU P F,MA J X,et al.TRPV4 activates the Cdc42/N-wasp pathway to promote glioblastoma invasion by altering cellular protrusions[J]. Sci Rep,2020,10(1):14151.
[44] FUJII S,TAJIRI Y,HASEGAWA K,et al.The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation[J]. Lab Invest,2020,100(2):311-323.
[45] HUANG R,WANG F,YANG Y,et al.Recurrent activations of transient receptor potential vanilloid-1 and vanilloid-4 promote cellular proliferation and migration in esophageal squamous cell carcinoma cells[J]. FEBS Open Bio,2019,9(2):206-225.
[46] ORONOWICZ J,REINHARD J,REINACH P S,et al.Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and-resistant retinoblastoma cells[J]. Lab Invest,2020,101(1):70-88.
[47] YANG S X,LU W,ZHAO C,et al.Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis[J]. Haematologica,2019,105(11):2572-2583. |
